The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mebendazole Market Research Report 2025
Synopsis
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The global Mebendazole market was valued at US$ 117.6 million in 2023 and is anticipated to reach US$ 173 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
This report aims to provide a comprehensive presentation of the global market for Mebendazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mebendazole.
Report Scope
The Mebendazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mebendazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mebendazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Segment by Type
Tablet
Oral Suspension
Segment by Application
Below 2 Years Old
Above 2 Years Old
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mebendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mebendazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
The global Mebendazole market was valued at US$ 117.6 million in 2023 and is anticipated to reach US$ 173 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
This report aims to provide a comprehensive presentation of the global market for Mebendazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mebendazole.
Report Scope
The Mebendazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mebendazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mebendazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Segment by Type
Tablet
Oral Suspension
Segment by Application
Below 2 Years Old
Above 2 Years Old
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mebendazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mebendazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Mebendazole Market Overview
1.1 Product Overview and Scope of Mebendazole
1.2 Mebendazole Segment by Type
1.2.1 Global Mebendazole Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Mebendazole Segment by Application
1.3.1 Global Mebendazole Market Value by Application: (2024-2030)
1.3.2 Below 2 Years Old
1.3.3 Above 2 Years Old
1.4 Global Mebendazole Market Size Estimates and Forecasts
1.4.1 Global Mebendazole Revenue 2019-2030
1.4.2 Global Mebendazole Sales 2019-2030
1.4.3 Global Mebendazole Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mebendazole Market Competition by Manufacturers
2.1 Global Mebendazole Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mebendazole Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mebendazole Average Price by Manufacturers (2019-2024)
2.4 Global Mebendazole Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mebendazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mebendazole, Product Type & Application
2.7 Mebendazole Market Competitive Situation and Trends
2.7.1 Mebendazole Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mebendazole Players Market Share by Revenue
2.7.3 Global Mebendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mebendazole Retrospective Market Scenario by Region
3.1 Global Mebendazole Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mebendazole Global Mebendazole Sales by Region: 2019-2030
3.2.1 Global Mebendazole Sales by Region: 2019-2024
3.2.2 Global Mebendazole Sales by Region: 2025-2030
3.3 Global Mebendazole Global Mebendazole Revenue by Region: 2019-2030
3.3.1 Global Mebendazole Revenue by Region: 2019-2024
3.3.2 Global Mebendazole Revenue by Region: 2025-2030
3.4 North America Mebendazole Market Facts & Figures by Country
3.4.1 North America Mebendazole Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mebendazole Sales by Country (2019-2030)
3.4.3 North America Mebendazole Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mebendazole Market Facts & Figures by Country
3.5.1 Europe Mebendazole Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mebendazole Sales by Country (2019-2030)
3.5.3 Europe Mebendazole Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mebendazole Market Facts & Figures by Country
3.6.1 Asia Pacific Mebendazole Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mebendazole Sales by Country (2019-2030)
3.6.3 Asia Pacific Mebendazole Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mebendazole Market Facts & Figures by Country
3.7.1 Latin America Mebendazole Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mebendazole Sales by Country (2019-2030)
3.7.3 Latin America Mebendazole Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mebendazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Mebendazole Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mebendazole Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mebendazole Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mebendazole Sales by Type (2019-2030)
4.1.1 Global Mebendazole Sales by Type (2019-2024)
4.1.2 Global Mebendazole Sales by Type (2025-2030)
4.1.3 Global Mebendazole Sales Market Share by Type (2019-2030)
4.2 Global Mebendazole Revenue by Type (2019-2030)
4.2.1 Global Mebendazole Revenue by Type (2019-2024)
4.2.2 Global Mebendazole Revenue by Type (2025-2030)
4.2.3 Global Mebendazole Revenue Market Share by Type (2019-2030)
4.3 Global Mebendazole Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mebendazole Sales by Application (2019-2030)
5.1.1 Global Mebendazole Sales by Application (2019-2024)
5.1.2 Global Mebendazole Sales by Application (2025-2030)
5.1.3 Global Mebendazole Sales Market Share by Application (2019-2030)
5.2 Global Mebendazole Revenue by Application (2019-2030)
5.2.1 Global Mebendazole Revenue by Application (2019-2024)
5.2.2 Global Mebendazole Revenue by Application (2025-2030)
5.2.3 Global Mebendazole Revenue Market Share by Application (2019-2030)
5.3 Global Mebendazole Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Mebendazole Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Mebendazole Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Amneal Pharmaceuticals
6.2.1 Amneal Pharmaceuticals Corporation Information
6.2.2 Amneal Pharmaceuticals Description and Business Overview
6.2.3 Amneal Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amneal Pharmaceuticals Mebendazole Product Portfolio
6.2.5 Amneal Pharmaceuticals Recent Developments/Updates
6.3 Cadila Pharmaceuticals
6.3.1 Cadila Pharmaceuticals Corporation Information
6.3.2 Cadila Pharmaceuticals Description and Business Overview
6.3.3 Cadila Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cadila Pharmaceuticals Mebendazole Product Portfolio
6.3.5 Cadila Pharmaceuticals Recent Developments/Updates
6.4 Eipico
6.4.1 Eipico Corporation Information
6.4.2 Eipico Description and Business Overview
6.4.3 Eipico Mebendazole Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Eipico Mebendazole Product Portfolio
6.4.5 Eipico Recent Developments/Updates
6.5 Esteve Pharmaceuticals
6.5.1 Esteve Pharmaceuticals Corporation Information
6.5.2 Esteve Pharmaceuticals Description and Business Overview
6.5.3 Esteve Pharmaceuticals Mebendazole Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Esteve Pharmaceuticals Mebendazole Product Portfolio
6.5.5 Esteve Pharmaceuticals Recent Developments/Updates
6.6 Tenry
6.6.1 Tenry Corporation Information
6.6.2 Tenry Description and Business Overview
6.6.3 Tenry Mebendazole Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tenry Mebendazole Product Portfolio
6.6.5 Tenry Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mebendazole Industry Chain Analysis
7.2 Mebendazole Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mebendazole Production Mode & Process
7.4 Mebendazole Sales and Marketing
7.4.1 Mebendazole Sales Channels
7.4.2 Mebendazole Distributors
7.5 Mebendazole Customers
8 Mebendazole Market Dynamics
8.1 Mebendazole Industry Trends
8.2 Mebendazole Market Drivers
8.3 Mebendazole Market Challenges
8.4 Mebendazole Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Mebendazole Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Mebendazole Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Mebendazole Market Competitive Situation by Manufacturers in 2023
Table 4. Global Mebendazole Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Mebendazole Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Mebendazole Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Mebendazole Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Mebendazole Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Mebendazole, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mebendazole, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mebendazole, Product Type & Application
Table 12. Global Key Manufacturers of Mebendazole, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mebendazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mebendazole as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mebendazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Mebendazole Sales by Region (2019-2024) & (K Units)
Table 18. Global Mebendazole Sales Market Share by Region (2019-2024)
Table 19. Global Mebendazole Sales by Region (2025-2030) & (K Units)
Table 20. Global Mebendazole Sales Market Share by Region (2025-2030)
Table 21. Global Mebendazole Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Mebendazole Revenue Market Share by Region (2019-2024)
Table 23. Global Mebendazole Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Mebendazole Revenue Market Share by Region (2025-2030)
Table 25. North America Mebendazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Mebendazole Sales by Country (2019-2024) & (K Units)
Table 27. North America Mebendazole Sales by Country (2025-2030) & (K Units)
Table 28. North America Mebendazole Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Mebendazole Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Mebendazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Mebendazole Sales by Country (2019-2024) & (K Units)
Table 32. Europe Mebendazole Sales by Country (2025-2030) & (K Units)
Table 33. Europe Mebendazole Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Mebendazole Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Mebendazole Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Mebendazole Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Mebendazole Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Mebendazole Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Mebendazole Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Mebendazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Mebendazole Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Mebendazole Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Mebendazole Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mebendazole Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Mebendazole Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Mebendazole Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Mebendazole Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Mebendazole Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Mebendazole Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Mebendazole Sales (K Units) by Type (2019-2024)
Table 51. Global Mebendazole Sales (K Units) by Type (2025-2030)
Table 52. Global Mebendazole Sales Market Share by Type (2019-2024)
Table 53. Global Mebendazole Sales Market Share by Type (2025-2030)
Table 54. Global Mebendazole Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Mebendazole Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Mebendazole Revenue Market Share by Type (2019-2024)
Table 57. Global Mebendazole Revenue Market Share by Type (2025-2030)
Table 58. Global Mebendazole Price (USD/Unit) by Type (2019-2024)
Table 59. Global Mebendazole Price (USD/Unit) by Type (2025-2030)
Table 60. Global Mebendazole Sales (K Units) by Application (2019-2024)
Table 61. Global Mebendazole Sales (K Units) by Application (2025-2030)
Table 62. Global Mebendazole Sales Market Share by Application (2019-2024)
Table 63. Global Mebendazole Sales Market Share by Application (2025-2030)
Table 64. Global Mebendazole Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Mebendazole Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Mebendazole Revenue Market Share by Application (2019-2024)
Table 67. Global Mebendazole Revenue Market Share by Application (2025-2030)
Table 68. Global Mebendazole Price (USD/Unit) by Application (2019-2024)
Table 69. Global Mebendazole Price (USD/Unit) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Mebendazole Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Amneal Pharmaceuticals Corporation Information
Table 76. Amneal Pharmaceuticals Description and Business Overview
Table 77. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Amneal Pharmaceuticals Mebendazole Product
Table 79. Amneal Pharmaceuticals Recent Developments/Updates
Table 80. Cadila Pharmaceuticals Corporation Information
Table 81. Cadila Pharmaceuticals Description and Business Overview
Table 82. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Cadila Pharmaceuticals Mebendazole Product
Table 84. Cadila Pharmaceuticals Recent Developments/Updates
Table 85. Eipico Corporation Information
Table 86. Eipico Description and Business Overview
Table 87. Eipico Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Eipico Mebendazole Product
Table 89. Eipico Recent Developments/Updates
Table 90. Esteve Pharmaceuticals Corporation Information
Table 91. Esteve Pharmaceuticals Description and Business Overview
Table 92. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Esteve Pharmaceuticals Mebendazole Product
Table 94. Esteve Pharmaceuticals Recent Developments/Updates
Table 95. Tenry Corporation Information
Table 96. Tenry Description and Business Overview
Table 97. Tenry Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Tenry Mebendazole Product
Table 99. Tenry Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Mebendazole Distributors List
Table 103. Mebendazole Customers List
Table 104. Mebendazole Market Trends
Table 105. Mebendazole Market Drivers
Table 106. Mebendazole Market Challenges
Table 107. Mebendazole Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mebendazole
Figure 2. Global Mebendazole Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Mebendazole Market Share by Type in 2023 & 2030
Figure 4. Tablet Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Mebendazole Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Mebendazole Market Share by Application in 2023 & 2030
Figure 8. Below 2 Years Old
Figure 9. Above 2 Years Old
Figure 10. Global Mebendazole Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Mebendazole Market Size (2019-2030) & (US$ Million)
Figure 12. Global Mebendazole Sales (2019-2030) & (K Units)
Figure 13. Global Mebendazole Average Price (USD/Unit) & (2019-2030)
Figure 14. Mebendazole Report Years Considered
Figure 15. Mebendazole Sales Share by Manufacturers in 2023
Figure 16. Global Mebendazole Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Mebendazole Players: Market Share by Revenue in 2023
Figure 18. Mebendazole Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Mebendazole Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Mebendazole Sales Market Share by Country (2019-2030)
Figure 21. North America Mebendazole Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Mebendazole Sales Market Share by Country (2019-2030)
Figure 25. Europe Mebendazole Revenue Market Share by Country (2019-2030)
Figure 26. Germany Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Mebendazole Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Mebendazole Revenue Market Share by Region (2019-2030)
Figure 33. China Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Mebendazole Sales Market Share by Country (2019-2030)
Figure 44. Latin America Mebendazole Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Mebendazole Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Mebendazole Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Mebendazole Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Mebendazole by Type (2019-2030)
Figure 54. Global Revenue Market Share of Mebendazole by Type (2019-2030)
Figure 55. Global Mebendazole Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Mebendazole by Application (2019-2030)
Figure 57. Global Revenue Market Share of Mebendazole by Application (2019-2030)
Figure 58. Global Mebendazole Price (USD/Unit) by Application (2019-2030)
Figure 59. Mebendazole Value Chain
Figure 60. Mebendazole Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
